Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
Profitability
Net margin0.5%-6.0pp6.6%+6.3pp0.2%
Returns
Return on equity1.1%-12.0pp13.2%+12.8pp0.4%
Efficiency
Asset turnover0.0×+0.1×0.0×0.0×0.0×
Liquidity
Current ratio3.5×-0.1×3.6×+0.3×3.3×-0.6×-0.2×4.1×+0.4×
Leverage
Debt-to-equity0.2×-0.1×0.3×+0.2×0.1×0.0×0.1×0.0×0.1×-0.4×
Per Share
Book value per share$1.91-17.0%$2.30+18.2%$1.95+12.0%$1.74-9.4%$1.92-3.7%
Valuation
Market capitalization$312.68M-23.7%$657.4M+22.8%$535.34M+22.0%$438.91M-19.9%$547.9M+36.2%
Price / sales0.6×-0.3×1.2×0.0×1.2×+0.1×-0.2×1.2×+0.4×
Price / book1.3×-0.4×2.2×+0.1×2.1×+0.2×1.9×-0.4×2.3×+0.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Organogenesis Holdings Inc.'s profit margins?
Organogenesis Holdings Inc. (ORGO) runs a 75.9% gross margin and a 0.5% operating margin, with a 0.5% net margin.
Where do Organogenesis Holdings Inc.'s ratios come from?
Every ratio is computed from Organogenesis Holdings Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.